1. Home
  2. CGEN vs GAIA Comparison

CGEN vs GAIA Comparison

Compare CGEN & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • GAIA
  • Stock Information
  • Founded
  • CGEN 1993
  • GAIA 1988
  • Country
  • CGEN Israel
  • GAIA United States
  • Employees
  • CGEN N/A
  • GAIA N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • GAIA Movies/Entertainment
  • Sector
  • CGEN Health Care
  • GAIA Consumer Discretionary
  • Exchange
  • CGEN Nasdaq
  • GAIA Nasdaq
  • Market Cap
  • CGEN 125.3M
  • GAIA 105.7M
  • IPO Year
  • CGEN 2000
  • GAIA 1999
  • Fundamental
  • Price
  • CGEN $1.65
  • GAIA $3.96
  • Analyst Decision
  • CGEN
  • GAIA Strong Buy
  • Analyst Count
  • CGEN 0
  • GAIA 2
  • Target Price
  • CGEN N/A
  • GAIA $8.00
  • AVG Volume (30 Days)
  • CGEN 324.9K
  • GAIA 42.6K
  • Earning Date
  • CGEN 11-10-2025
  • GAIA 11-03-2025
  • Dividend Yield
  • CGEN N/A
  • GAIA N/A
  • EPS Growth
  • CGEN N/A
  • GAIA N/A
  • EPS
  • CGEN N/A
  • GAIA N/A
  • Revenue
  • CGEN $6,903,000.00
  • GAIA $98,622,000.00
  • Revenue This Year
  • CGEN N/A
  • GAIA $13.81
  • Revenue Next Year
  • CGEN $208.08
  • GAIA $15.74
  • P/E Ratio
  • CGEN N/A
  • GAIA N/A
  • Revenue Growth
  • CGEN N/A
  • GAIA 14.80
  • 52 Week Low
  • CGEN $1.13
  • GAIA $2.93
  • 52 Week High
  • CGEN $2.66
  • GAIA $6.53
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 46.42
  • GAIA 24.81
  • Support Level
  • CGEN $1.54
  • GAIA $4.07
  • Resistance Level
  • CGEN $1.79
  • GAIA $4.48
  • Average True Range (ATR)
  • CGEN 0.11
  • GAIA 0.30
  • MACD
  • CGEN -0.01
  • GAIA -0.08
  • Stochastic Oscillator
  • CGEN 34.62
  • GAIA 5.29

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

Share on Social Networks: